Central venous thrombosis in patients receiving long-term parenteral nutrition

Applied Physiology, Nutrition and Metabolism

Volumn 33, Issue 1, 2008, Pages 32-38

  Duerksen, Donald R ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Central venous thrombosis; Home parenteral nutrition; Vitamin K

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; VITAMIN K GROUP; WARFARIN;

CENTRAL VENOUS CATHETERIZATION; DIET THERAPY; GASTROINTESTINAL DISEASE; HUMAN; PARENTERAL NUTRITION; REVIEW; TIME; VEIN THROMBOSIS;

ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; GASTROINTESTINAL DISEASES; HUMANS; PARENTERAL NUTRITION, HOME; TIME FACTORS; VENOUS THROMBOSIS; VITAMIN K; WARFARIN;

EID: 39749122609     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-153     Document Type: Review

References (51)

1. Abu-Elmagd, K.M. 2006. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology, 130: S132-S137. doi:10.1053/j.gastro.2005.09.069.
2. ASPEN Board of Directors and the Clinical Guidelines Task Force. 2002. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J. Parenter. Enteral. Nutr. 26: 36A-37A.
3. Bern, M. 2004. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy. JPEN J. Parenter. Enteral Nutr. 28: 388-398.
4. Bern, M.M., Bothe, A., Jr., Bistrian, B., Champagne, C.D., Keane, M.S., and Blackburn, G.L. 1986. Prophylaxis against central vein thrombosis with low-dose warfarin. Surgery, 99: 216-221.
5. Blom, J.W., Doggen, C.J., Osanto, S., and Rosendaal, F.R. 2005. Old and new risk factors for upper extremity deep venous thrombosis. J. Thromb. Haemost. 3: 2471-2478. doi:10.1111/j.1538-7836.2005.01625.x.
6. Booth, S.L., Pennington, J.A., and Sadowski, J.A. 1996. Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: data from the FDA Total Diet Study. J. Am. Diet. Assoc. 96: 149-154. doi:10.1016/S0002-8223(96)00044-2.
7. Camilo, M.E., Jatoi, A., O'Brien, M., Davidson, K., Sokoll, L., Sadowski, J.A., and Mason, J.B. 1998. Bioavailability of phylloquinone from an intravenous lipid emulsion. Am. J. Clin. Nutr. 67: 716-721.
8. Chambrier, C., Leclercq, M., Saudin, F., Vignal, B., Bryssine, S., Guillaumont, M., and Bouletreau, P. 1998. Is vitamin K1 supplementation necessary in long-term parenteral nutrition? JPEN J. Parenter. Enteral Nutr. 22: 87-90.
9. Conly, J., and Stein, K. 1994. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin. Invest. Med. 17: 531-539.
10. Conly, J.M., Stein, K., Worobetz, L., and Rutledge-Harding, S. 1994. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am. J. Gastroenterol. 89: 915-923.
11. Couban, S., Goodyear, M., Burnell, M., Dolan, S., Wasi, P., Barnes, D., et al. 2005. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J. Clin. Oncol. 23: 4063-4069. doi:10.1200/JCO.2005.10.192.
12. Crowther, M.A., Douketis, J.D., Schnurr, T., Steidl, L., Mera, V., Ultori, C., et al. 2002. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann. Intern. Med. 137: 251-254.
13. Crowther, M.A., Ageno, W., Schnurr, T., Manfredi, E., Kinnon, K., Garcia, D., and Douketis, J.D. 2005. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Haematologica, 90: 137-139.
14. Delegge, M., Alsolaiman, M.M., Barbour, E., Bassas, S., Siddiqi, M.F., and Moore, N.M. 2007. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today? Dig. Dis. Sci. 52: 876-892. doi:10.1007/s10620-006-9416-6.
15. Drittij-Reijnders, M.J., Sels, J.P., Rouflart, M., and Thijssen, H.H. 1994. Vitamin K status and parenteral nutrition: the effect of Intralipid on plasma vitamin K1 levels. Eur. J. Clin. Nutr. 48: 525-527.
16. Duerksen, D.R., and Papineau, N. 2003. Is routine vitamin K required in hospitalized patients receiving lipid-based parenteral nutrition? JPEN J. Parenter. Enteral Nutr. 28: 30-33.
17. Duerksen, D.R., Ahmad, A., Doweiko, J., Bistrian, B.R., and Mascioli, E.A. 1996. Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 20: 302-305.
18. Elduayen, B., Martinez-Cuesta, A., Vivas, I., Delgado, C., Pueyo, J.C., and Bilbao, J.I. 2000. Central venous catheter placement in the inferior vena cava via the direct translumbar approach. Eur. Radiol. 10: 450-454. doi:10.1007/s003300050074.
19. Elman, E.E., and Kahn, S.R. 2006. The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb. Res. 117: 609-614. doi:10.1016/j. thromres.2005.05.029.
20. Ferland, G., and Sadowski, J.A. 1992. The vitamin K2 (phylloquinone) content of edible oils: Effects of heating and light exposure. J. Agric. Food Chem. Res. 40: 1869-1873. doi:10.1021/jf00022a028.
21. Food and Nutrition Board and National Research Council. 1989. Fat soluble vitamins. In Recommended dietary allowances. 10th ed. National Academy Press, Washington, D.C. pp. 107-114.
22. Food and Nutrition Board and Institute of Medicine. 2001. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington, D.C.
23. Garber, A.K., Binkley, N.C., Krueger, D.C., and Suttie, J.W. 1999. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. J. Nutr. 129: 1201-1203.
24. Hamilton, H.C., and Foxcroft, D.R. 2007. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database Syst. Rev. 3: CD004084.
25. Helphingstine, C.J., and Bistrian, B.R. 2003. New food and drug administration requirements for inclusion of vitamin K in adult parenteral multivitamins. JPEN J. Parenter. Enteral Nutr. 27: 220-224.
26. Howard, L., and Ashley, C. 2003. Management of complications in patients receiving home parenteral nutrition. Gastroenterology, 124: 1651-1661. doi:10.1016/S0016-5085(03)00326-3.
27. Hylek, E.M. 2003. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors. Semin. Vasc. Med. 3: 271-278. doi:10.1055/s-2003-44463.
28. Jeejeebhoy, K.N. 2006. Management of short bowel syndrome: avoidance of total parenteral nutrition. Gastroenterology, 130: S60-S66. doi:10.1053/j.gastro.2005.10.065.
29. Katz, D.S., and Hon, M. 2004. Current DVT imaging. Tech. Vasc. Interv. Radiol. 7: 55-62. doi:10.1053/j.tvir.2004.02.002.
30. Kutsop, J.J. 1984. Update on vitamin K1 content of enteral products. Am. J. Hosp. Pharm. 41: 1762.
31. Labourey, J.L., Lacroix, P., Genet, D., Gobeaux, F., Martin, J., Venat-Bouvet, L., et al. 2004. Thrombotic complications of implanted central venous access devices: prospective evaluation. Bull. Cancer, 91: 431-436.
32. Lennon, C., Davidson, K.W., Sadowski, J.A., and Mason, J.B. 1993. The vitamin K content of intravenous lipid emulsions. JPEN J. Parenter. Enteral Nutr. 17: 142-144.
33. Luciani, A., Clement, O., Halimi, P., Goudot, D., Portier, F., Bassot, V., et al. 2001. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology, 220: 655-660. doi:10.1148/radiol. 2203001181.
34. Lutomski, D.M., Palascak, J.E., and Bower, R.H. 1987. Warfarin resistance associated with intravenous lipid administration. JPEN J. Parenter. Enteral Nutr. 11: 316-318.
35. MacLaren, R., Wachsman, B.A., Swift, D.K., and Kuhl, D.A. 1997. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature. Pharmacotherapy, 17: 1331-1337.
36. Monreal, M., Raventos, A., Lerma, R., Ruiz, J., Lafoz, E., Alastrue, A., and Llamazares, J.F. 1994. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines - a prospective study. Thromb. Haemost. 72: 548-550.
37. Monreal, M., Munoz, F.J., Rosa, V., Romero, C., Roman, P., Di Micco, P., and Prandoni, P. 2006. Upper extremity DVT in oncological patients: analysis of risk factors. Data from the RIETE registry. Exp. Oncol. 28: 245-247.
38. Mustafa, S., Stein, P.D., Patel, K.C., Otten, T.R., Holmes, R., and Silbergleit, A. 2003. Upper extremity deep venous thrombosis. Chest, 123: 1953-1956. doi:10.1378/chest.123.6.1953.
39. Newall, F., Barnes, C., Savoia, H., Campbell, J., and Monagle, P. 2003. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics, 112: e386. doi:10.1542/peds.112. 5.e386.
40. Pettei, M.J., Israel, D., and Levine, J. 1993. Serum vitamin K concentration in pediatric patients receiving total parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 17: 465-467.
41. Prandoni, P., and Bernardi, E. 1999. Upper extremity deep vein thrombosis. Curr. Opin. Pulm. Med. 5: 222-226. doi:10.1097/00063198- 199907000-00008.
42. Reese, A.M., Farnett, L.E., Lyons, R.M., Patel, B., Morgan, L., and Bussey, H.I. 2005. Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy, 25: 1746-1751. doi:10.1592/phco.2005.25.12.1746.
43. Rice, T.W., Rodriguez, R.M., and Light, R.W. 2006. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore), 85: 37-42. doi:10.1097/01.md.0000198474.99876.f0.
44. Ryder, M.A. 1995. Peripheral access options. Surg. Oncol. Clin. N. Am. 4: 395-427.
45. Scolapio, J.S., Fleming, C.R., Kelly, D.G., Wick, D.M., and Zinsmeister, A.R. 1999. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin. Proc. 74: 217-222.
46. Shevchuk, Y.M., and Conly, J.M. 1990. Antibiotic-associated hypoprothrombinemia: a review of prospective studies, 1966-1988. Rev. Infect. Dis. 12: 1109-1126.
47. Steiger, E. 2006a. Consensus statements regarding optimal management of home parenteral nutrition (HPN) access. JPEN J. Parenter. Enteral Nutr. 30: S94-S95.
48. Steiger, E. 2006b. Dysfunction and thrombotic complications of vascular access devices. J. Parenter. Enteral Nutr. 30: S70-S72.
49. Suttie, J.W. 2006. Vitamin K. In Modern nutrition in health and disease. Edited by M.E. Shils, M. Shike, A.C. Ross, and B.C.R.J. Caballero. Lippincott, Williams & Wilkins, Baltimore, Md. pp. 363-380.
50. Veerabagu, M.P., Tuttle-Newhall, J., Maliakkal, R., Champagne, C., and Mascioli, E.A. 1995. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients. Nutrition, 11: 142-144.
51. Woods, K., Douketis, J.D., Kathirgamanathan, K., Yi, Q., and Crowther, M.A. 2007. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J. Thromb. Thrombolysis, In press.